|
1
|
Stadtländer CT and Waterbor JW: Molecular
epidemiology, pathogenesis and prevention of gastric cancer.
Carcinogenesis. 20:2195–2208. 1999.
|
|
2
|
Ren J, Chen Z, Juan SJ, Yong XY, Pan BR
and Fan DM: Detection of circulating gastric carcinoma-associated
antigen MG7-Ag in human sera using an established single
determinant immuno-polymerase chain reaction technique. Cancer.
88:280–285. 2000. View Article : Google Scholar
|
|
3
|
Tischoff I and Tannapfel A: DNA
methylation in hepatocellular carcinoma. World J Gastroenterol.
14:1741–1748. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis: epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Riggs AD and Pfeifer GP: X-chromosome
inactivation and cell memory. Trends Genet. 8:169–174. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Razin A and Cedar H: DNA methylation and
genomic imprinting. Cell. 77:473–476. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thim L and May FE: Structure of mammalian
trefoil factors and functional insights. Cell Mol Life Sci.
62:2956–2973. 2005.PubMed/NCBI
|
|
8
|
Ribieras S, Tomasetto C and Rio MC: The
pS2/TFF1 trefoil factor, from basic research to clinical
applications. Biochim Biophys Acta. 1378:F61–F77. 1998.PubMed/NCBI
|
|
9
|
Corte MD, Tamargo F, Alvarez A, Rodríguez
JC, Vázquez J, Sánchez R, Lamelas ML, González LO, Allende MT,
García-Muñiz JL, Fueyo A and Vizoso F: Cytosolic levels of TFF1/pS2
in breast cancer: their relationship with clinical-pathological
parameters and their prognostic significance. Breast Cancer Res
Treat. 96:63–72. 2006. View Article : Google Scholar
|
|
10
|
Rio MC, Bellocq JP, Daniel JY, Tomasetto
C, Lathe R, Chenard MP, Batzenschlager A and Chambon P: Breast
cancer-associated pS2 protein: synthesis and secretion by normal
stomach mucosa. Science. 241:705–708. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taupin D, Pedersen J, Familari M, Cook G,
Yeomans N and Giraud AS: Augmented intestinal trefoil factor (TFF3)
and loss of pS2 (TFF1) expression precedes metaplastic
differentiation of gastric epithelium. Lab Invest. 81:397–408.
2001. View Article : Google Scholar
|
|
12
|
Carvalho R, Kayademir T, Soares P, Canedo
P, Sousa S, Oliveira C, Leistenschneider P, Seruca R, Gött P, Blin
N, Carneiro F and Machado JC: Loss of heterozygosity and promoter
methylation, but not mutation, may underlie loss of TFF1 in gastric
carcinoma. Lab Invest. 82:1319–1326. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Katoh M: Trefoil factors and human gastric
cancer (review). Int J Mol Med. 12:3–9. 2003.
|
|
14
|
McChesney PA, Aiyar SE, Lee OJ, Zaika A,
Moskaluk C, Li R and El-Rifai W: Cofactor of BRCA1: a novel
transcription factor regulator in upper gastrointestinal
adenocarcinomas. Cancer Res. 66:1346–1353. 2006. View Article : Google Scholar
|
|
15
|
Park WS, Oh RR, Park JY, Yoo NJ, Lee SH,
Shin MS, Kim SY, Kim YS, Lee JH, Kim HS, An WG and Lee JY: Mapping
of a new target region of allelic loss at 21q22 in primary gastric
cancers. Cancer Lett. 159:15–21. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ribieras S, Lefèbvre O, Tomasetto C and
Rio MC: Mouse Trefoil factor genes: genomic organization, sequences
and methylation analyses. Gene. 266:67–75. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fujimoto J, Yasui W, Tahara H and Tahara
E, Kudo Y, Yokozaki H and Tahara E: DNA hypermethylation at the pS2
promoter region is associated with early stage of stomach
carcinogenesis. Cancer Lett. 149:125–134. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tomita H, Takaishi S, Menheniott TR, Yang
X, Shibata W, Jin G, Betz KS, Kawakami K, Minamoto T, Tomasetto C,
Rio MC, Lerkowit N, Varro A, Giraud AS and Wang TC: Inhibition of
gastric carcinogenesis by the hormone gastrin is mediated by
suppression of TFF1 epigenetic silencing. Gastroenterology.
140:879–891. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park WS, Oh RR, Park JY, Lee JH, Shin MS,
Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NJ and Lee JY: Somatic
mutations of the trefoil factor family 1 gene in gastric cancer.
Gastroenterology. 119:691–698. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sankpal NV, Mayo MW and Powell SM:
Transcriptional repression of TFF1 in gastric epithelial cells by
CCAAT/enhancer binding protein-beta. Biochim Biophys Acta.
1728:1–10. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calnan DP, Westley BR, May FE, Floyd DN,
Marchbank T and Playford RJ: The trefoil peptide TFF1 inhibits the
growth of the human gastric adenocarcinoma cell line AGS. J Pathol.
188:312–317. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lefebvre O, Chenard MP, Masson R, Linares
J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P and Rio
MC: Gastric mucosa abnormalities and tumorigenesis in mice lacking
the pS2 trefoil protein. Science. 274:259–262. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng Z, Chen J, Wei H, Gao P, Shi J, Zhang
J and Zhao F: The risk factor of gallbladder cancer: hyperplasia of
mucous epithelium caused by gallstones associates with
p16/CyclinD1/CDK4 pathway. Exp Mol Pathol. 91:569–577. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Liu H, Chen K, Xiao J, He K, Zhang
J and Xiang G: SIRT1 promotes tumorigenesis of hepatocellular
carcinoma through PI3K/PTEN/AKT signaling. Oncol Rep. 28:311–318.
2012.PubMed/NCBI
|
|
25
|
Li L, Zhang J, Yang Y, Wang Q, Gao L, Yang
Y, Chang T, Zhang X, Xiang G, Cao Y, Shi Z, Zhao M and Gao G:
Single-wall carbon nanohorns inhibited activation of microglia
induced by lipopolysaccharide through blocking of Sirt3. Nanoscale
Res Lett. 8:1002013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Bergeron L, Cryns V, Pasternack MS,
Zhu H, Shi L, Greenberg A and Yuan J: Activation of caspase-2 in
apoptosis. J Biol Chem. 272:21010–21017. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fenoglio-Preisern CM, Wang J, Stemmermann
GN and Noffsinger A: TP53 and gastric carcinoma: a review. Hum
Mutat. 21:258–270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tahara E: Genetic pathways of two types of
gastric cancer. IARC Sci Pub. 157:327–349. 2004.PubMed/NCBI
|
|
29
|
Ballestar E and Wolffe AP:
Methyl-CpG-binding proteins. Targeting specific gene repression.
Eur J Biochem. 268:1–6. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Babyatsky MW, deBeaumont M, Thim L and
Podolsky DK: Oral trefoil peptides protect against ethanol and
indomethacin-induced gastric injury in rats. Gastroenterology.
110:489–497. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pera M, Heppell J, Poulsom R, Teixeira FV
and Williams J: Ulcer associated cell lineage glands expressing
trefoil peptide genes are induced by chronic ulceration in ileal
pouch mucosa. Gut. 48:792–796. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Newton JL, Allen A, Westley BR and May FE:
The human trefoil peptide, TFF1, is present in different molecular
forms that are intimately associated with mucus in normal stomach.
Gut. 46:312–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Herath NI, Leggett BA and MacDonald GA:
Review of genetic and epigenetic alterations in
hepatocarcinogenesis. J Gastroenterol Hepatol. 21:15–21. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li HP, Leu YW and Chang YS: Epigenetic
changes in virus-associated human cancers. Cell Res. 15:262–271.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Herceg Z: Epigenetics and cancer: towards
an evaluation of the impact of environmental and dietary factors.
Mutagenesis. 22:91–103. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Adrien LR, Schlecht NF, Kawachi N, Smith
RV, Brandwein-Gensler M, Massimi A, Chen S, Prystowsky MB, Childs G
and Belbin TJ: Classification of DNA methylation patterns in tumor
cell genomes using a CpG island microarray. Cytogenet Genome Res.
114:16–23. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lund AH and van Lohuizen M: Epigenetics
and cancer. Genes Dev. 18:2315–2335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sparmann A and van Lohuizen M: Polycomb
silencers control cell fate, development and cancer. Nat Rev
Cancer. 6:846–856. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Baylin SB: Mechanisms underlying
epigenetically mediated gene silencing in cancer. Semin Cancer
Biol. 12:331–337. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hur K, Song SH, Lee HS, Ho Kim W, Bang YJ
and Yang HK: Aberrant methylation of the specific CpG island
portion regulates cyclooxygenase-2 gene expression in human gastric
carcinomas. Biochem Biophys Res Commun. 310:844–851. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee TL, Leung WK, Chan MW, Ng EK, Tong JH,
Lo KW, Chung SC, Sung JJ and To KF: Detection of gene promoter
hypermethylation in the tumor and serum of patients with gastric
carcinoma. Clin Cancer Res. 8:1761–1766. 2002.PubMed/NCBI
|
|
42
|
Carvalho B, Pinto M, Cirnes L, Oliveira C,
Machado JC, Suriano G, Hamelin R, Carneiro F and Seruca R:
Concurrent hypermethylation of gene promoters is associated with a
MSH-H phenotype and diploidy in gastric carcinomas. Eur J Cancer.
39:1222–1227. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Byun DS, Lee MG, Chae KS, Ryu BG and Chi
SG: Frequent epigenetic inactivation of RASSF1A by aberrant
promoter hypermethylation in human gastric adenocarcinoma. Cancer
Res. 61:7034–7038. 2001.PubMed/NCBI
|
|
44
|
Sozzi G, Conte D, Leon M, Ciricione R, Roz
L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA
and Pastorino U: Quantification of free circulating DNA as a
diagnostic marker in lung cancer. J Clin Oncol. 21:3902–3908. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Toyota M and Issa JP: The role of DNA
hypermethylation in human neoplasisa. Electrophoresis. 21:329–333.
2000. View Article : Google Scholar
|
|
46
|
Poulsen SS, Thulesen J, Christensen L,
Nexo E and Thim L: Metabolism of oral trefoil factor 2 (TFF2) and
the effect of oral and parenteral TFF2 on gastric and duodenal
ulcer healing in the rat. Gut. 45:516–522. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wong WM, Poulsom R and Wright NA: Trefoil
peptides. Gut. 44:890–895. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Longman RJ, Douthwaite J, Sylvester PA,
Poulsom R, Corfield AP, Thomas MG and Wright NA: Coordinated
localisation of mucins and trefoil peptides in the ulcer associated
cell lineage and the gastrointestinal mucosa. Gut. 47:792–800.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dignass A, Lynch-Devaney K, Kindon H, Thim
L and Podolsky DK: Trefoil peptides promote epithelial migration
through a transforming growth factor beta-independent pathway. J
Clin Invest. 94:376–383. 1994. View Article : Google Scholar : PubMed/NCBI
|
